Research on joint application of chrysanthemum morifolium and aclarubicin in promoting HL-60 cells apoptosis

CHEN Gang,WANG Jian-chao,ZHAO Hong-can,YAO Hang-ping,FAN Jian,TONG Xiang-min
2013-01-01
Abstract:Objective To explore the effects of combined use of chrysanthemum morifolium and aclarubicin on inducing apoptosis of leukemia cells( HL-60). Methods Leukemia cells( HL-60) were treated with aclarubicin at the dose of 0. 05 μg /ml,0. 1 μg / ml,0. 25 μg / ml,chrysanthemum morifolium at the concentration of 500 μM,and chrysanthemum morifolium at the concentration of 10 μM,100 μM,500 μM in the presence of low dose of aclarubicin( 0. 1 μg / mL) for 20 h respectively.Then the apoptotic rate was analyzed by flow cytometry,the protein expression of COX-2,NF-kB,caspase 3 and caspase 9were estimated by Western-blot method. Results Low-concentration aclarubicin had little effect on apoptotic rate of HL-60cells,as well as caspase 3,caspase 9,COX-2,NF-κB expressions on HL-60 cells. Combined treatment of chrysanthemum morifolium and lower-concentration aclarubicin can enhance the apoptotic rate,expression of caspase 3 and caspase 9,down-regulate COX-2 expression. This effect was highly correlated with the concentration of chrysanthemum morifolium. NF-κB activity was obviously suppressed by combination of chrysanthemum morifolium and aclarubicin. Conclusion Chrysanthemum morifolium can enhance the aclarubicin-mediated apoptotic effect on HL-60 cells,up-regulate expression of caspase 3 and caspase 9,down-regulate COX-2 expression in HL-60 cells via suppressing activity of NF-κB.
What problem does this paper attempt to address?